Skip to main content

Synpromics, a Scottish-based synthetic biology company, forms part of the Calculus VCT

Synpromics is developing a portfolio of synthetic promoters for application across target markets which include Cell & Gene Therapy and Bioprocessing, find out more.

For a full archive of investment company videos, subscribe to the AIC's YouTube channel.

Back to all videos

Sign up for Compass

The AIC monthly e-newsletter for private investors

Subscribe to Statistics

The monthly breakdowns for our industry


View the latest investment company announcements or search the 12 month archive.

View announcements